|
|
||||||||
RI in human basophils


* Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, and
Virginia Commonwealth University, Richmond, Virginia
Correspondence: Dr. Donald MacGlashan, Jr., Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224. E-mail: dmacglas{at}jhmi.edu
Expression of the high-affinity receptor on basophils and mast cells is
modulated by immunoglobulin E (IgE) antibody. Recent studies have shown
that modulation occurs through interaction of IgE with the receptor
itself, but the mechanisms underlying this control are not understood.
Taking both a theoretical and experimental approach, we examined
several competing models that focus on whether there is IgE-regulated
loss, IgE-regulated synthesis, or both regulated loss and synthesis of
the Fc receptor for IgE (Fc
RI). We report that removing IgE from
occupied Fc
RI resulted in an accelerated loss only in the unoccupied
receptor, with no loss of occupied receptors and no loss of total
receptors when all receptors were occupied. Together with previous
studies, these results establish that there was IgE-regulated loss of
receptors. An examination of synthetic rates of Fc
RI
using
pulse-labeling with 35S-methionine indicated no difference
in synthetic rates in the presence or absence of IgE. Similarly, the
presence or absence of IgE had no influence on the levels of mRNA for
either
, ß, or
subunits of Fc
RI. Using model simulations,
we found that regulated-synthesis models could be distinguished from
regulated-loss/constant-synthesis models on the basis of the
relationship between starting Fc
RI densities and changes in density
after culture for 1 week in the absence of IgE. Experimental data from
this type of study fit a regulated-loss model that did not include
regulation of synthesis. Taken together, these results suggest that IgE
regulates cell surface expression of Fc
RI only by regulating the
rate that receptor is lost from the cell surface.
Key Words: regulated loss regulated synthesis receptor
This article has been cited by other articles:
![]() |
D. W. MacGlashan Jr. Endocytosis, recycling, and degradation of unoccupied Fc{epsilon}RI in human basophils J. Leukoc. Biol., October 1, 2007; 82(4): 1003 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gomez, S. Jogie-Brahim, M. Shima, and L. B. Schwartz Omalizumab Reverses the Phenotypic and Functional Effects of IgE-Enhanced Fc{epsilon}RI on Human Skin Mast Cells J. Immunol., July 15, 2007; 179(2): 1353 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Schroeder, A. P. Bieneman, H. Xiao, K. L. Chichester, K. Vasagar, S. Saini, and M. C. Liu TLR9- and Fc{epsilon}RI-Mediated Responses Oppose One Another in Plasmacytoid Dendritic Cells by Down-Regulating Receptor Expression J. Immunol., November 1, 2005; 175(9): 5724 - 5731. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. MacGLASHAN JR. IgE and Fc{epsilon}RI Regulation Ann. N.Y. Acad. Sci., June 1, 2005; 1050(1): 73 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mack, M. A. Schneider, C. Moll, J. Cihak, H. Bruhl, J. W. Ellwart, M. P. Hogarth, M. Stangassinger, and D. Schlondorff Identification of Antigen-Capturing Cells as Basophils J. Immunol., January 15, 2005; 174(2): 735 - 741. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |